James Stevenson
Abramson Cancer Center at Penn Medicine · Eastern Cooperative Oncology Group · Cooper Norcross Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name James Stevenson as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:21 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01112293 · Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural MesotheliomaAbramson Cancer Center at Penn Medicine · completed · Pleural Malignant Mesothelioma · principal investigator
- Ph2NCT01105390 · AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaNational Cancer Institute (NCI) · withdrawn · Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Recurrent Malignant Mesothelioma · principal investigator
- Ph2NCT00254319 · Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)Cooper Norcross Health · unknown · Untreated Advanced Non-Small Cell Lung Cancer · principal investigator
- Ph2NCT00040768 · Bortezomib in Treating Patients With Advanced Non-small Cell Lung CancerNational Cancer Institute (NCI) · terminated · Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer · principal investigator
- Ph3NCT00032084 · S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone SurgerySWOG Cancer Research Network · terminated · Lung Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:21 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 4 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Eastern Cooperative Oncology Group Operations OfficeU10CA021115 · NCI · FRONTIER SCI & TECHNOLOGY RSCH FDN, INC · PI ROBERT L COMIS · fiscal years 1985 to 2013Named on NCT01105390
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:21 UTC. The ranking covers the 200 most relevant of 164 PubMed records, and a shared surname and initials can bring in a namesake. All 164 on PubMed
- 1,193 citationsRCR 35.0
- 484 citationsRCR 16.5
- Mechanisms of hypertension associated with BAY 43-9006.J Clin Oncol · 2006262 citationsRCR 5.7
- Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.JACC Cardiovasc Interv · 2018252 citationsRCR 10.5
- 250 citationsRCR 10.1
- 246 citationsRCR 5.7
- Clonidine treatment of Gilles de la Tourette's syndrome.Arch Gen Psychiatry · 1991243 citationsRCR 11.0
- Comparison of e-mail, fax, and postal surveys of pediatricians.Pediatrics · 2003213 citationsRCR 6.9
- Melatonin administration to blind people: phase advances and entrainment.J Biol Rhythms · 1991197 citationsRCR 9.2
- Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.Metabolism · 1993195 citationsRCR 7.4